1. Home
  2. BMEA vs SPE Comparison

BMEA vs SPE Comparison

Compare BMEA & SPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMEA
  • SPE
  • Stock Information
  • Founded
  • BMEA 2017
  • SPE 1993
  • Country
  • BMEA United States
  • SPE United States
  • Employees
  • BMEA N/A
  • SPE N/A
  • Industry
  • BMEA Biotechnology: Pharmaceutical Preparations
  • SPE Finance/Investors Services
  • Sector
  • BMEA Health Care
  • SPE Finance
  • Exchange
  • BMEA Nasdaq
  • SPE Nasdaq
  • Market Cap
  • BMEA 145.0M
  • SPE 158.8M
  • IPO Year
  • BMEA 2021
  • SPE N/A
  • Fundamental
  • Price
  • BMEA $4.25
  • SPE $15.07
  • Analyst Decision
  • BMEA Buy
  • SPE
  • Analyst Count
  • BMEA 13
  • SPE 0
  • Target Price
  • BMEA $27.92
  • SPE N/A
  • AVG Volume (30 Days)
  • BMEA 831.0K
  • SPE 25.4K
  • Earning Date
  • BMEA 10-29-2024
  • SPE 01-01-0001
  • Dividend Yield
  • BMEA N/A
  • SPE 8.55%
  • EPS Growth
  • BMEA N/A
  • SPE N/A
  • EPS
  • BMEA N/A
  • SPE N/A
  • Revenue
  • BMEA N/A
  • SPE N/A
  • Revenue This Year
  • BMEA N/A
  • SPE N/A
  • Revenue Next Year
  • BMEA N/A
  • SPE N/A
  • P/E Ratio
  • BMEA N/A
  • SPE N/A
  • Revenue Growth
  • BMEA N/A
  • SPE N/A
  • 52 Week Low
  • BMEA $3.61
  • SPE $10.26
  • 52 Week High
  • BMEA $20.21
  • SPE $12.59
  • Technical
  • Relative Strength Index (RSI)
  • BMEA 42.32
  • SPE 56.37
  • Support Level
  • BMEA $3.78
  • SPE $14.50
  • Resistance Level
  • BMEA $4.29
  • SPE $15.17
  • Average True Range (ATR)
  • BMEA 0.30
  • SPE 0.28
  • MACD
  • BMEA 0.15
  • SPE 0.04
  • Stochastic Oscillator
  • BMEA 89.71
  • SPE 86.36

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

About SPE Special Opportunities Fund Inc

Special Opportunities Fund Inc is the United States based closed-ended diversified management investment company. Its investment objective is to have the total return. The company's investment portfolio consists of investment companies, common stocks, money market funds, commodity partnerships, preferred stocks, convertible bonds, liquidating trusts, promissory notes, senior unsecured notes, warrants, rights, corporate notes and corporate bonds. In addition, it also makes investments in construction materials, consumer finance, healthcare equipment and supplies, independent power and renewable electricity producers, insurance, personal products, professional services and real estate investment trusts.

Share on Social Networks: